Komori
Astellas Pharma (4503) · RiskFirst stated

Impact on corporate culture and reputation from inadequate coordination of organizational change

First written in FY2025. . Latest entry: FY2025.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Deterioration of Corporate Culture and Reputation Due to Insufficient Coordination of Organizational TransformationA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025First statedAnnual report

    「複数の取り組みを同時に実施する際には、相互関係を理解し、調整することが肝要です。こういった調整が不十分なまま組織変革が実行された場合、当社のカルチャーや外部からの評判に影響する可能性があります。」

    複数の組織変革を同時に進める際の調整不足を、企業文化及び外部評判への影響につながり得る新たなグローバルリスクとして記載した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Astellas Pharma's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact on corporate culture and reputation from inadequate coordination of organizational change | Astellas Pharma Inc. (4503) | Komori